Mitsubishi Tanabe ups profit forecast on lower costs
This article was originally published in Scrip
Executive Summary
Lower than expected costs in the first half have led Japan's Mitsubishi Tanabe Pharma (MTP) to raise its consolidated net profit guidance for the first half ended September 30th by ¥3.5 billion to ¥13.5 billion ($149.5 million).